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Summary: A new enzymatic method for direct photometric determination of oxalate in serum and urine is described,
using oxalate oxidase. The resulting H202 is measured with a coupled enzyme system of catalase and aldehyde de-
hydrogenase. Percentage recovery of added oxalate was 99 ± 4 in serum, and 98 ± 4 in urine (n = 10). Oxalate serum
levels varied from 16.9 to 44.8 μηηοΙ/L Oxalate values can be determined within 20 minutes, without time consuming
pretreatment of samples. The detection limit is 5 μπιοΐ/ΐ.
Direkte spektrophotometrische Bestimmung von Serum- und Urin-Oxalat mit Oxalat-Oxidase
Zusammenfassung: Es wird eine neue enzymatische Methode zur direkten photometrischen Bestimmung von Oxalat
in Serum und Urin mittels Oxalatoxidase beschrieben. In einer gekoppelten Reaktion wird H202 enzymatisch durch
Katalase und Aldehyddehydrogenase gemessen. Die Wiederfindung von zugesetztem Oxalat betrug 99 ± 4% in Serum
und 98 ± 4% in Urin (n = 10). Die Oxalatkonzentrationen in Serum variierten von 16,9 bis 44,8 /imol/l. Oxalatwerte
k nnen ohne zeitraubende Probenvorbehandlung innerhalb 20 Minuten ermittelt werden. Die Erfassungsgrenze liegt
bei 5 μπιοΐ/ΐ.
Introduction
Reliable measurement of oxalate is required in the
investigation of calcium urolithiasis and various intestinal
diseases with enteric hyperoxaluria. In the majority of
published methods for oxalate determination, extraction
or precipitation steps are necessary. Moreover, known
methods lack specif!ty (2).
There are two possible enzymatic reactions for the de-
gradation of oxalate: Decarboxylation by oxalate de-
carboxylase (oxalate carboxy-lyase, EC 4.1.1.2) and
oxidation by oxalate oxidase (oxalate: oxygen oxido-
reductase, EC 1.2.3.4). The former reaction has been
used by various authors (3-8), but has proved unsuitable
for routine purposes. The latter reaction was introduced
by the present authors in 1978 (9, 10).
There are various approaches to the measurement of the
degradation products, CO2 and H2O2. If CO2 is meas-
ured, the assay is twice as sensitive as that based on the
decarboxylation (11). However, there are difficulties in
the determination of oxalate in serum, especially with
regard to the high endogeneous concentration of CO2.
We therefore evaluated various H2O2 assays. The catalass/
aldehyde dehydrogenase reaction for H2O2 determina-
tion (12) is widely accepted in laboratory practice be-
cause of its specifity. We coupled this reaction with the
oxidation of oxalate (10), and in the present paper we ·
have adapted the procedure for a simple and quick deter-
mination of oxalate in serum and urine:
oxalate oxidase(COOH)2 + 02 2C02 + H202
catalase
H2O2 + ethanol ·* acetaldehyde + 2H20
acetaldehyde + NADP+ aldehyde acetate + NADPH
+ H2O dehydrogenase + H*
Material and Methods
Reagents
Catalase (hydrogen peroxide: hydrogen peroxide oxidoreductase,
EC 1.11.1.6): Boehringer Mannheim No. 106810.
Parts of this publication were presented at an international
meeting in London, 1979 (1).
0340-076X/81/0019-1103502.00
© by Walter de Gruyter & Co. - Berlin - New York
1104 Kohlbecker and Butz: Direct spectrophotometric determination of oxalate
Aldehyde dehydrogenase (aldehyde: NAD(P)oxidoreductase,
EC 1.2.1.5): Sigma No. A 6758 (Reactivated from baker's yeast).
Oxalate oxidase (oxalate: oxygen oxidoreductase, EC 1.2.3.4),
was isolated from barley seedlings (13). After extraction with
H20, contaminating proteins were removed by heat denatura-
tion and fractional ammonium sulfate precipitation (45-65%
saturation). The enzyme.was further purified by ion exchange
chromatography on DEAE-Sephadex A-50, with imidazole buffer,
I = 0.05, pH 8 and elution with a NaCl gradient. From 1 kg
seedlings we obtained 6 mg enzyme protein free of protease and
catalase with a specific activity of about 15 U/mg (37 °C,
50 mmol/1 succinate buffer pH 3.8). Partially purified enzyme
preparations containing catalase activity are also suitable for
oxalate determination by the aldehyde dehydrogenase method,
but for reasons of stability they should not contain protease. The
preparation was stable as a solution (2 g/1) in 5 mmol/1 succinate
buffer pH 3.8 containing 5 mmol/1 EDTA and 20 mg/1 merthiol-
ate for at least 6 months at 4 °C. Commercially available enzyme
can also be used (Boehringer Mannheim No. 567698).
NADP*: Boehringer Mannheim No. 127 353.
All other chemicals were obtained as p. a. grade from Merck
(Darmstadt).
Equipment
Instruments from Eppendorf Ger tebau GmbH (Hamburg) were
used: Photometer 1101 M with recorder.
Ultrafilter cones Centriflo CF 25 were purchased from Amicon
GmbH (Witten).
Solutions
1: Succinate (5 mmol/1) buffer pH 3.8 + 5 mmol/1 EDTA:
Dissolve 590 mg succinic acid + 1.86 g EDTA in about 900 ml
H20, adjust pH to 3.8 with NaOH and adjust to 1 1 with H2O.
2: This solution is prepared fresh daily:
16 ml ethanol and 500 μΐ (= 650 kU) catalase are added to
100 ml solution 1.
3: Diphosphate (180 mmol/1) buffer pH 9.0 + 90 mmol/1 KC1:
Dissolve 80.2 g Na4P2O7 - 10H2O + 6.71 g KC1 in about 900 ml
H20, adjust pH to 9.0 with HC1 and adjust to 11 with H2O.
4: This solution is prepared fresh daily:
l g NADP in added to 11 solution 3.
5: Oxalate oxidase: 500 mg/1 in solution 1.
6: Aldehyde dehydrogenase: 7.5 kU/1 H20.
Sample pretreatment
Urine
Either fresh or stored (HC1 preserved) urine is diluted in a pro-
portion of 1:10 with succinate buffer containing EDTA (solu-
tion 1).
Serum
Proteins with molecular weights above 25000 are removed by
ultrafiltration. About 3 ml serum are transferred to ultrafilter
cones and rotated for 3 min at 750 g. Under these conditions,
approx. 1.5 ml of protein-free ultrafiltrate with no decrease in
the oxalate concentration are obtained. pH is adjusted to a value
between 3.5 and 4.5 with 10 μΐ 2 mol/1 HC1 per 1 ml ultrafiltrate.
Procedure (tab. 1)
The reaction buffer, containing EDTA, ethanol and catalase, is
transferred to sample and blank vessels. The sample (diluted
urine or deprotemized serum) is added to both, the blank and
the sample vessel, and the reaction in the sample vessel is started
by addition of oxalate oxidase. Hydrogen peroxide, from the
oxidation of the oxalate, oxidizes ethanol to acetaldehyde in the
presence of catalase.
15 min later, the pH is made alkaline by adding a buffer solution
of pH 9, containing the coenzyme NADP*. The indicator reaction
is started by aldehyde dehydrogenase. Acetaldehyde, generated in
the first reaction step, is now oxidized to acetate; this oxidation
Tab. 1. Assay procedure.
Sample: either serum ultrafiltrate or diluted (1:10) urine
Solution 2
Sample
Oxalate oxidase, solution 5
Solution 1
Incubate 15 min at approx. 20 °C
Solution 4
Aldehyde dehydrogenase, solution 6
Sample
(Ml)
150
50
10
200
10
t\ ~ *) /»m
Read ΔΑ33~4 nm of sample against blank after at least
(Ai).
Blank
(Ml)
150
50
10
200
10
3 min
In order to eliminate the absorbance value of oxalate oxidase, an
additional 10 μΐ oxalate oxidase are pipetted into a sample vessel,
and the resulting absorbance difference (A2), which can be used
for all samples, is subtracted from every sample: AI - A2 = AS.
Calculation:
Urine c = A? · 6800 (μηιοΐ/ΐ)
Serum ultrafiltrate c = A3 · 680 (μπιοΐ/ΐ)
(Molar lineic absorbance: 6*34°,^ ? = 6.18 · 103 1 · mol'1 · cnf1
= 618m2.mor1).
is coupled with the reduction of NADP*. NADPH, equimolecular
with the original oxalate, is measured photometrically at 334 nm.
The sample value is read against a blank. The oxalate concentra-
tion is calculated from the absorbance value without reference to
a standard solution.
When the oxidation of acetaldehyde is finished, a continuous in-
crease of absorbance is observed, which varies between individual
samples. This nonspecific increase of absorbance can be quantita-
tively reduced, if NADP* is used instead of NAD*. Nevertheless,
the use of a recorder is advisable and allows extrapolation of the
absorbance reading to the start of the aldehyde dehydrogenase
reaction (fig. 1).
0.200 -
Fig. 1. Reaction kinetics of a serum ultrafiltrate measurement.
Simultaneous recording of the absorbance of 1) blank,
2) sample, 3) sample with 2.5 nm'ol oxalate added.
Oxalate concentration c = 680 « Δ A = 39.4 μιηοΐ/ΐ sample.
Recovery of added oxalate: 2.45 nmol
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Results
We determined the following values as criteria of the
method:
1. Limit of detection
Using the method of Kaiser (14), the detection limit was
calculated from the spread of blank values (threefold
standard deviation). For serum this is 5 μιηοΐ/ΐ, for urine
20 /zmol/1.
2. Specificity
The enzyme oxalate oxidase is strictly specific for
oxalate. No other substrates have been found. The ma-
jority of H2O2 assays are disturbed by reducing agents
such as ascorbic acid. Ascorbic acid was added in varying
concentrations to urine samples. Ascorbate concentra-
tions in the range tested (0—5 mmol/1) had no influence
on the measured oxalate concentration.
However, a nonspecific increase of absorbance, which
was independent of the specific acetaldehyde dehydrogen-
ase reaction, was observed. The slope of this increase
correlates to the ascorbate concentration in the sample.,
If ascorbate oxidase (EC 1.10.3.3) is added, this absorb-
ance phenomenon is not detectable. It should be noted
that the measured oxalate concentration is not altered,
as blank and sample have identical absorbance slopes.
3. Accuracy
Linearity
In a concentration range of 0—8 nmol oxalate/sample
linearity is observed (fig. 2). For serum (50 μΐ) the cor-
responding final concentration range is Or-160 μτηοΐ/l,
for urine (5 μΐ) 0—1.6 mmol/1.
Recovery
To analyzed samples, 2.5 nmol of oxalate were added.
Recovery in urine was 98 ± 4% (n = 10), in serum
99 ± 4% (n= 10) (tab. 2).
Tab. 2. Oxalate concentration of urine and serum samples and
analytical recovery of oxalate added.
2.5 nmol oxalate were added to the previously analyzed
samples and oxalate concentrations were measured again.
Sample
1
2
3
4
5
6
7
8
9
10
x±SD
Urine
Oxalate
concentra-
tion
(μηιοΐ/ΐ)
143
298
145
347
476
200
177
363
238
309
270 ±108
Recovery
of 2.5 nmol
oxalate
added
(%)
100
95
103
97
99
94
102
91
95
104
98 ±4
Serum
Oxalate
concentra-
tion
(μπιοΐ/ΐ)
33.6
31.8
33.9
40.3
16.9
23.4
44.8
39.2
28.7
35.5
32.8 ±8
Recovery
of 2.5 nmol
oxalate added
(%)
96
101
103
98
102
99
104
98
92
101
99 ±4
Comparison of methods
In 8 urine samples, oxalate was analyzed either by meas-
urement of C02 (11) or the method described. The coeffi-
cient of correlation was 0.9530 (fig. 3).
1 2 3 4. 5 6 7
Oxalate weighed in [nmol/assay 3
Fig. 2. Correlation between different concentrations of oxalate in
aqueous solutions and the amount of oxalate found.
Analysis of regression: y = 1.0106 χ - 0.0284 (η = 5)
χ = 4.00, y=4.01, r = 0.9988
600
= 500
l400
5-300
σ 200
ο
100
Ο 100 200 300 400 500 600
OxalGte (aldehyde dehydrogenase method) fumol/l]
Fig. 3. Comparison of oxalate concentrations found in various
urine samples as measured by the present aldehyde de-
hydrogenase method and a CO2 method (11).
Regression analysis: y = 0.9995 χ + 6.7504 (η = 8)
χ = 269, y = 275, r = 0.9530
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4. Reproducibility (n=10)
Serum
The reproducibility among a series was 35.4 ± 1.1 jumol/l
(CV = 3.1%), from day to day 34.3 ± 1.3 μιηοΐ/ΐ (CV =
Urine
The reproducibility among a series was 200 ± 9 μτηοΐ/ΐ
(CV = 4.5%), from day to day 203 ± 12 (CV = 5.S
Discussion
There is general agreement on the fundamental disadvan-
tages of any method for the estimation of oxalate, which
is based on extraction of the oxalate. Direct measurement
of oxalate in urine as well as in serum is possible by the
use of oxalate oxidase.
We formerly ruled out various possibilities for the estima-
tion of the H202 produced in the oxalate oxidation (9,
10). In comparison with colorimetric methods (15,16),
reactions coupled with NAD+/NADPf seem to be advan-
tageous. According to Haeckel (17) the catalase/aldehyde
dehydrogenase reaction for the estimation of H202 is
highly specific. Sixty compounds that often occur in
serum and urine were shown not to interfere. Especially
ascorbic acid might be expected to disturb H202-pro-
ducing reactions, because of its high physiological
concentration in urine. We demonstrated that ascorbic
acid has no influence on the measured oxalate concen-
tration in urine. The detection limit of the method also
permits the estimation of serum oxalate. There is still
much controversy (2) about the true oxalate value in
serum and its significance with regard to disturbances
of oxalate metabolism (18) or urolithiasis (19).
The serum values measured by our method can be com-
pared to those obtained by Hatch et al. (8) with a differ-
ent enzymatic method. To us, sample pretreatment
seems to be a crucial point. Ultrafiltration has proved to
be a reliable method for serum deproteinization. Accord-
ing to our experiments with [14C]oxalate arid those of
other authors (20), oxalate is freely filtrable at a physio-
logical pH. There is no need for alkalinization as de-
scribed by others (8).
The enzymatic method commonly used for determina-
tion of urinary oxalate is that introduced byHallson &
Rose (6). Using modified reaction vessels and substituting
decarboxylase by oxidase, we achieved higher sensitivity
and accuracy for the method (11). However, oxalate can
only be measured after an incubation time of at least
16 hours.
In contrast, the spectrophotometric approach of meas-
uring H202 allows estimation of oxalate within 20 min-
utes. Thus, larger series are feasible, especially as a calibra-
tion curve is not necessary. The concentration can be
calculated directly, using the lineic molar absorbarice of
NADPH.
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